De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.


Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 15 07 2021
revised: 15 03 2022
accepted: 05 04 2022
pubmed: 25 4 2022
medline: 1 6 2022
entrez: 24 4 2022
Statut: ppublish

Résumé

Heterozygous POLR2A variants have been recently reported in patients with a neurodevelopmental syndrome characterized by profound infantile-onset hypotonia. POLR2A encodes the highly conserved RBP1 protein, an essential subunit of the DNA-dependent RNA polymerase II. We investigated a 12-year-old girl presenting with an early-onset encephalopathy characterized by psychomotor delay, facial dysmorphism, refractory epilepsy with variable seizure types, behavioural abnormalities, and sleep disorder. Brain MRI showed a slowly progressive cerebellar atrophy. Trio-exome sequencing (Trio-ES) revealed the de novo germline variant NM_000937.5:c.1370T>C; p.(Ile457Thr) in POLR2A. This variant was previously reported in a subject with profound generalized hypotonia and muscular atrophy by Haijes et al. Our patient displayed instead a severe epileptic phenotype with refractory hypotonic seizures with impaired consciousness, myoclonic jerks, and drop attacks. This case expands the clinical spectrum of POLR2A-related syndrome, highlighting its phenotypic variability and supporting the relevance of epilepsy as a core feature of this emerging condition.

Sections du résumé

BACKGROUND BACKGROUND
Heterozygous POLR2A variants have been recently reported in patients with a neurodevelopmental syndrome characterized by profound infantile-onset hypotonia. POLR2A encodes the highly conserved RBP1 protein, an essential subunit of the DNA-dependent RNA polymerase II.
CASE PRESENTATION METHODS
We investigated a 12-year-old girl presenting with an early-onset encephalopathy characterized by psychomotor delay, facial dysmorphism, refractory epilepsy with variable seizure types, behavioural abnormalities, and sleep disorder. Brain MRI showed a slowly progressive cerebellar atrophy. Trio-exome sequencing (Trio-ES) revealed the de novo germline variant NM_000937.5:c.1370T>C; p.(Ile457Thr) in POLR2A. This variant was previously reported in a subject with profound generalized hypotonia and muscular atrophy by Haijes et al. Our patient displayed instead a severe epileptic phenotype with refractory hypotonic seizures with impaired consciousness, myoclonic jerks, and drop attacks.
CONCLUSION CONCLUSIONS
This case expands the clinical spectrum of POLR2A-related syndrome, highlighting its phenotypic variability and supporting the relevance of epilepsy as a core feature of this emerging condition.

Identifiants

pubmed: 35461703
pii: S0387-7604(22)00060-2
doi: 10.1016/j.braindev.2022.04.002
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-485

Informations de copyright

Copyright © 2022 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Auteurs

Thea Giacomini (T)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy; Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Electronic address: giacomini.thea@gmail.com.

Marcello Scala (M)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy. Electronic address: marcelloscala87@gmail.com.

Giulia Nobile (G)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy. Electronic address: giulianobile@gaslini.org.

Mariasavina Severino (M)

Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Electronic address: mariasavinaseverino@gaslini.org.

Domenico Tortora (D)

Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Electronic address: domenicotortora@gaslini.org.

Lino Nobili (L)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy; Unit of Child Neuropsychiatry, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Electronic address: lino.nobili@unige.it.

Andrea Accogli (A)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy. Electronic address: andreaccogli@gaslini.org.

Annalaura Torella (A)

Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, Italy; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. Electronic address: annalaura.torella@gmail.com.

Valeria Capra (V)

Medical Genetic Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Electronic address: valeriacapra@gaslini.org.

Maria Margherita Mancardi (MM)

Unit of Child Neuropsychiatry, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Electronic address: margheritamancardi@gaslini.org.

Vincenzo Nigro (V)

Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, Italy; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. Electronic address: vincenzo.nigro@unicampania.it.
Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH